Marker Therapeutics Inc (MRKR)

[poods]

They are simply saying the product did what they had hoped. The infused cells propagated/expanded in the patient, but as or more importantly, those T-cells created an immune response that recruited other T-cells directed at other tumor associated antigen targets than were not included in the original infused T-cell product. "i.e. epitope/antigen spreading"